The human papillomavirus (HPV) is responsible for several types of cancer, including roughly 13,000 new cases of cervical cancer per year in the United States. New research led by the University of Washington’s Population Health Initiative and the London School of Hygiene and Tropical Medicine’s Vaccine Confidence Project suggests that tailored, locally informed interventions can help address barriers and improve HPV vaccine uptake. The study, which was published in the journal Vaccine, investigated the factors behind HPV vaccine hesitancy and…
Initiative-led research offers recommendations for improving HPV vaccine uptake









